- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
CTI takes over cyclotron marketing
Siemens Medical Systems has ceded responsibility for global cyclotronsales and marketing to its PET partner, Computer Technology Imaging(CTI) of Knoxville, TN. The move enables Siemens to focus on marketingits PET products, according to Thomas Cafarella,
Siemens Medical Systems has ceded responsibility for global cyclotronsales and marketing to its PET partner, Computer Technology Imaging(CTI) of Knoxville, TN. The move enables Siemens to focus on marketingits PET products, according to Thomas Cafarella, group vice presidentof Siemens' nuclear medicine unit in Hoffman Estates, IL.
Siemens acquired marketing rights to CTI's PET scanner and RadioisotopeDelivery System (RDS) cyclotron through an investment and marketingagreement in 1987 (SCAN 11/25/87). Siemens will continue to handlesales and support of the ECAT PET line and will arrange for CTIsupport of cyclotron service contracts currently in place.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
